Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emma Guttman

Showing results (251-260 of 387) with videos related to

Pageof 39
Sort By:
Allergy|September 30, 2022
Delayed type hypersensitivity reactions to various allergens may differently model inflammatory skin diseasesAna B Pavel, Ester Del Duca, Julia Cheng, et al.
The Journal of Allergy and Clinical Immunology|October 7, 2015
Diverse activation and differentiation of multiple B-cell subsets in patients with atopic dermatitis but not in patients with psoriasisTali Czarnowicki, Juana Gonzalez, Kathleen M Bonifacio, et al.
The Journal of Investigative Dermatology|April 17, 2018
The Major Orphan Forms of Ichthyosis Are Characterized by Systemic T-Cell Activation and Th-17/Tc-17/Th-22/Tc-22 Polarization in BloodTali Czarnowicki, Helen He, Alexandra Leonard, et al.
BMJ Open|November 28, 2020
International observational atopic dermatitis cohort to follow natural history and treatment course: TARGET-DERM AD study design and rationaleKatrina Abuabara, Jonathan I Silverberg, Eric L Simpson, et al.
Dermatitis : Contact, Atopic, Occupational, Drug|August 18, 2021
Transcriptomic Profiling of Tape-Strips From Moderate to Severe Atopic Dermatitis Patients Treated With DupilumabDaniela Mikhaylov, Ester Del Duca, Caroline Meyer Olesen, et al.
JAMA Dermatology|June 21, 2023
Hyperactivation of the JAK2/STAT5 Signaling Pathway and Evaluation of Baricitinib Treatment Among Patients With Eosinophilic CellulitisJohanna Morot, Ester Del Duca, Marine Chastagner, et al.
Dermatology and Therapy|June 18, 2026
Three-Year Efficacy and Safety of Lebrikizumab in Patients with Moderate-to-Severe Atopic Dermatitis: A Long-Term Extension (ADjoin)Emma Guttman-Yassky, Alan D Irvine, Melinda Gooderham, et al.
Allergy|May 31, 2024
Mapping the immune cell landscape of severe atopic dermatitis by single-cell RNA-seqSeon-Pil Jin, Kyungchun Lee, Yoon Ji Bang, et al.
The Journal of Allergy and Clinical Immunology|October 6, 2016
Major differences between human atopic dermatitis and murine models, as determined by using global transcriptomic profilingDavid A Ewald, Shinji Noda, Margeaux Oliva, et al.
The Journal of Investigative Dermatology|June 18, 2024
A Review of Atomic-Force Microscopy in Skin Barrier Function AssessmentJorge Pereda, Casper Milde Khatib, Sanja Kezic, et al.
Pageof 39

Showing results (251-260 of 387) with videos related to

Sort By:
Pageof 39
Allergy|September 30, 2022
Delayed type hypersensitivity reactions to various allergens may differently model inflammatory skin diseasesAna B Pavel, Ester Del Duca, Julia Cheng, et al.
The Journal of Allergy and Clinical Immunology|October 7, 2015
Diverse activation and differentiation of multiple B-cell subsets in patients with atopic dermatitis but not in patients with psoriasisTali Czarnowicki, Juana Gonzalez, Kathleen M Bonifacio, et al.
The Journal of Investigative Dermatology|April 17, 2018
The Major Orphan Forms of Ichthyosis Are Characterized by Systemic T-Cell Activation and Th-17/Tc-17/Th-22/Tc-22 Polarization in BloodTali Czarnowicki, Helen He, Alexandra Leonard, et al.
BMJ Open|November 28, 2020
International observational atopic dermatitis cohort to follow natural history and treatment course: TARGET-DERM AD study design and rationaleKatrina Abuabara, Jonathan I Silverberg, Eric L Simpson, et al.
Dermatitis : Contact, Atopic, Occupational, Drug|August 18, 2021
Transcriptomic Profiling of Tape-Strips From Moderate to Severe Atopic Dermatitis Patients Treated With DupilumabDaniela Mikhaylov, Ester Del Duca, Caroline Meyer Olesen, et al.
JAMA Dermatology|June 21, 2023
Hyperactivation of the JAK2/STAT5 Signaling Pathway and Evaluation of Baricitinib Treatment Among Patients With Eosinophilic CellulitisJohanna Morot, Ester Del Duca, Marine Chastagner, et al.
Dermatology and Therapy|June 18, 2026
Three-Year Efficacy and Safety of Lebrikizumab in Patients with Moderate-to-Severe Atopic Dermatitis: A Long-Term Extension (ADjoin)Emma Guttman-Yassky, Alan D Irvine, Melinda Gooderham, et al.
Allergy|May 31, 2024
Mapping the immune cell landscape of severe atopic dermatitis by single-cell RNA-seqSeon-Pil Jin, Kyungchun Lee, Yoon Ji Bang, et al.
The Journal of Allergy and Clinical Immunology|October 6, 2016
Major differences between human atopic dermatitis and murine models, as determined by using global transcriptomic profilingDavid A Ewald, Shinji Noda, Margeaux Oliva, et al.
The Journal of Investigative Dermatology|June 18, 2024
A Review of Atomic-Force Microscopy in Skin Barrier Function AssessmentJorge Pereda, Casper Milde Khatib, Sanja Kezic, et al.
Pageof 39